We are delighted to announce Terumo Interventional Systems as the latest addition to our Corporate Partnership programme. Terumo Interventional Systems, a division of Terumo Europe N.V., is pushing boundaries in interventional medicine as a market leader in minimally invasive entry site management, lesion access, closure and interventional technologies in cardiology, peripheral and oncology.
As a corporate partner, Terumo Interventional Systems will be part of the Biopôle life sciences community, with access to our innovation pipeline, business intelligence and premium infrastructure. As the first Medtech to join our programme, it will offer unique expertise and exposure to our MedTech Biopôle members. Terumo Interventional Systems’ international experience, especially in the Europe Middle East and Africa is another special advantage to any of its future collaborators. In return, thanks to this partnership, Terumo Interventional Systems will be able to strengthen its emerging activities in digital health.
Ghada Farah, Senior Vice President, Terumo Interventional Systems-EMEA, explains how the partnership will benefit Terumo Interventional Systems: ‘We are excited to be partnering with an innovative organisation like Biopôle and anticipate many opportunities to grow from our work together unleashing opportunities for patients from digital health solutions and from product innovations.’
